Recursion Pharmaceuticals' Series B Round

Recursion Pharmaceuticals raised a round of funding on October 03, 2017.

Recursion Pharmaceuticals leverages biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including …

Articles about Recursion Pharmaceuticals' Series B Round: